Trial
NCT02918266
TAK-071 Scopolamine-Induced Cognitive Impairment Study
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Takeda
Collaborators
—
Condition
Healthy Volunteers
Intervention
Scopolamine
Why stopped
Terminated prematurely due to indication change.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-06-14